Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Jul 2026 for Aptose Biosciences Inc.. Read the official filing
Filing timeline
BuySaleRafael Bejar
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+0.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Rafael Bejar: trading record in brief
Rafael Bejar is a declared insider of Aptose Biosciences Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 19 November 2021 to 30 June 2026.
Every open-market trade on record is a purchase: 1 purchase worth €23k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant.
The record was last updated on 1 July 2026 with a transaction in Aptose Biosciences Inc. The clock since the last published purchase (19 November 2021) now reads 1,794 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rafael Bejar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
244 sharesCommon SharesSEC:0000912282-26-000893:0
100,000 shares0Common SharesSEC:0001567619-23-001153:0
10,000 shares@ US$2.56100.0% of flowCommon SharesSEC:0001567619-21-020906:0
Canonical exit: 17 Feb 2022 (T+90)
3 of 3 declarations
